Skip to main content
As the leading kidney research charity in the UK, nothing is going to stop us in our urgent mission to end kidney disease. We’re here to be heard, to make a difference, to change the future. This is a disease that ruins and destroys lives. It must be stopped.

Over the past 60 years, our research has made an impact. But kidney failure is rising, as are the factors contributing to it, such as diabetes and obesity.

Today, we are more essential than ever.

Kidney disease affects three million people in the UK, treatments can be gruelling and currently there is no cure. Only research will end this and nobody can do it but us, by offering kidney patients and their families hope for the future. We’re taking it on. But we can’t do it without you.
King's Business is responsible for driving innovation at King's College London. Through the development of new opportunities and partnerships we optimise the impact of research and create value for the College in its externally-facing activities. This includes securing partnerships with business and other sectors through diverse mechanisms such as patenting and licensing, the creation of spin-out companies, collaborative and contract research, consultancy and staff secondments to and from industry.
KISS - the multiplier agency.

An award-winning B2B marketing agency where expertise meets an unwavering desire for exceptional results. If you’re ambitious about multiplying the impact of your marketing performance, we are the agency to help your grow your business.

Fuelled by a team of experts across strategy, creativity, technology and performance, we will amplify your marketing performance and grow your business through our theory of multiplication: Creativity x Technology x Data.

We harness the power of creativity to ensure you stand out in the marketplace, enabling this with the latest technology. Everything we do is informed by data to deliver your message through the right channels, to the right audiences, at the right time to deliver maximum impact.

From concept to completion, our projects multiply results.
Growth is good. Multiplying is better.
No data available
No data available
No data available
Labmode are the main UK agents for Taylor Wharton cryogenics products and can offer consultation and advice on sample storage solutions through to installation of biobanking sample storage facilities in the UK and worldwide. We are focused on providing storage solutions not just liquid nitrogen delivery systems. Labmode can supply all areas of a cryogenic installation with the key drivers being: end-user safety, ergonomics, and providing the most efficient installation possible. Products we supply:. . •
LBIC provides laboratories, offices and technical support to over 40 life science product and diagnostic companies, CROs, medical device companies and associated service providers. Our Virtual Client package is a risk-free option for companies looking to establish a presence in London without incurring the expense of setting up an office, or employing staff on the ground. LBIC is located 10 minutes' walk from St Pancras International, Eurostar and the site of the Francis Crick Institute. LBIC is owned by the Royal Veterinary College (RVC), the UK’s largest and longest-established veterinary institution and a leading centre for comparative and translational medicine. Watch our Member Showcase Video https://bit.ly/33RExnm
LEX Diagnostics is a spin out from TTP plc, a leading technology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. We formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. . The new name reflects the charity’s purpose: to be the arc or bridge between research and improving patients’ lives.. . LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. . . So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance. . . https://www.lifearc.org Twitter @lifearc1.